The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final analysis of 2-THE-TOP: A phase 2 study of TTFields (Optune) plus pembrolizumab plus maintenance temozolomide (TMZ) in patients with newly diagnosed glioblastoma.
 
David D. Tran
Honoraria - Novocure
Consulting or Advisory Role - Novocure
Research Funding - Lacerta Therapeutics; Merck; Monteris Medical; Novocure; Sarepta Therapeutics
Patents, Royalties, Other Intellectual Property - A molecular cell diary system; AAV capsid variants targeting human glioblastoma stem-like cells; Chemotherapeutic resensitization of disseminated cancer stem cells through reactivation by p38 inhibition and IL-6 inhibition - chemotherapeutic methods; Core master regulators of glioblastoma stem cells; Direct conversion of human mesenchymal stem cells to human cardiomyocytes; GeneRep and nSCORE: Method and apparatus for improved determination of node influence in a network; Immunotherapy for direct reprogramming of cancer cells into immune cells/antigen presenting cells/dendritic cells; Inhibiting prostaglandin e receptor 3 resensitizes resistant cells to TTFields and prevents cells from developing resistance to TTFields; Methods and compositions for determining susceptibility to treatment with checkpoint inhibitors; Methods for cancer screening and monitoring by cancer master regulators markers in liquid biopsy; Methods for reducing viability of cancer cells by activation of the STING pathway with TTFields; Methods for targeted treatment and prediction of patient survival in cancer
Travel, Accommodations, Expenses - Novocure
 
Ashley Parham Ghiaseddin
Consulting or Advisory Role - Novocure
 
Dongjiang D. Chen
Honoraria - Novocure
Patents, Royalties, Other Intellectual Property - Novocure
 
Son B Le
No Relationships to Disclose